139 related articles for article (PubMed ID: 1778220)
1. Expression of transferrin receptors by monocytes and peritoneal macrophages from renal failure patients treated by continuous ambulatory peritoneal dialysis (CAPD).
Moughal NA; McGregor SJ; Brock JH; Briggs JD; Junor BJ
Eur J Clin Invest; 1991 Dec; 21(6):592-6. PubMed ID: 1778220
[TBL] [Abstract][Full Text] [Related]
2. Release of hydrogen peroxide and expression of HLA-DR and transferrin receptors by monocytes and peritoneal macrophages from patients undergoing continuous ambulatory peritoneal dialysis and normal controls.
McGregor SJ; Brock JH; Briggs JD; Junor BJ
Clin Immunol Immunopathol; 1990 Aug; 56(2):151-8. PubMed ID: 2379325
[TBL] [Abstract][Full Text] [Related]
3. Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients.
Goldstein CS; Bomalaski JS; Zurier RB; Neilson EG; Douglas SD
Kidney Int; 1984 Nov; 26(5):733-40. PubMed ID: 6596459
[TBL] [Abstract][Full Text] [Related]
4. Activation of immunocompetent cells in the peritoneum of patients treated with CAPD.
Davies SJ; Suassuna J; Ogg CS; Cameron JS
Kidney Int; 1989 Oct; 36(4):661-8. PubMed ID: 2811064
[TBL] [Abstract][Full Text] [Related]
5. Difference in the blood monocyte phenotype between uremic patients and healthy controls: its relation to monocyte differentiation into macrophages in the peritoneal cavity.
Brauner A; Lu Y; Halldén G; Hylander B; Lundahl J
Inflammation; 1998 Feb; 22(1):55-66. PubMed ID: 9484650
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal production of erythropoietin with continuous ambulatory peritoneal dialysis.
Chandra M; Clemons G; Sahdev I; McVicar M; Bluestone P
Pediatr Nephrol; 1993 Jun; 7(3):281-3. PubMed ID: 8518099
[TBL] [Abstract][Full Text] [Related]
7. Selenium metabolism in patients on continuous ambulatory peritoneal dialysis.
Apostolidis NS; Panoussopoulos DG; Stamou KM; Kekis PB; Paradellis TP; Karydas AG; Zarkadas C; Zirogiannis PN; Manouras AJ
Perit Dial Int; 2002; 22(3):400-4. PubMed ID: 12227400
[TBL] [Abstract][Full Text] [Related]
8. Losses of 25-hydroxyvitamin D in peritoneal fluid: possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis.
Aloni Y; Shany S; Chaimovitz C
Miner Electrolyte Metab; 1983; 9(2):82-6. PubMed ID: 6601753
[TBL] [Abstract][Full Text] [Related]
9. Increased endothelin-1 mRNA expression in peripheral blood monocytes of dialysis patients.
Ebihara I; Nakamura T; Takahashi T; Tomino Y; Shimada N; Koide H
Perit Dial Int; 1997; 17(6):595-601. PubMed ID: 9655160
[TBL] [Abstract][Full Text] [Related]
10. Losses of 1,25- and 24,25-dihydroxycholecalciferol in the peritoneal fluid of patients treated with continuous ambulatory peritoneal dialysis.
Shany S; Rapoport J; Goligorsky M; Yankowitz N; Zuili I; Chaimovitz C
Nephron; 1984; 36(2):111-3. PubMed ID: 6607420
[TBL] [Abstract][Full Text] [Related]
11. Properties of human peritoneal macrophages from continuous ambulatory peritoneal dialysis (CAPD) patients.
McGregor SJ; Brock JH; Briggs JD; Junor BJ
FEMS Microbiol Immunol; 1989 Apr; 1(5):303-4. PubMed ID: 2631872
[No Abstract] [Full Text] [Related]
12. Fibronectin and complement secretion by monocytes and peritoneal macrophages in vitro from patients undergoing continuous ambulatory peritoneal dialysis.
Goldstein CS; Garrick RE; Polin RA; Gerdes JS; Kolski GB; Neilson EG; Douglas SD
J Leukoc Biol; 1986 Apr; 39(4):457-64. PubMed ID: 3456405
[TBL] [Abstract][Full Text] [Related]
13. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
[TBL] [Abstract][Full Text] [Related]
14. Serum CA-125 level in end-stage renal disease patients maintained on chronic peritoneal dialysis or hemodialysis: the effect of continuous presence of peritoneal fluid, peritonitis, and peritoneal catheter implantation.
Bastani B; Chu N
Am J Nephrol; 1995; 15(6):468-72. PubMed ID: 8546167
[TBL] [Abstract][Full Text] [Related]
15. Blood and peritoneal levels of endothelin in continuous ambulatory peritoneal dialysis patients.
Vlassopoulos D; Deray G; Carayon A; Maistre G; Jacobs C
Nephron; 1995; 69(3):273-6. PubMed ID: 7753260
[TBL] [Abstract][Full Text] [Related]
16. [Functional activity of monocytes-macrophages and neutrophils of blood and peritoneal effluent in patients with end-stage kidney failure maintained by permanent peritoneal dialysis at an outpatient setting].
Romanova LA; Lugovskaia SA; Shutov EV; Levina AA; Frolova OE; Korovina VI
Klin Lab Diagn; 2001 Mar; (3):44-7. PubMed ID: 12014080
[No Abstract] [Full Text] [Related]
17. Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients.
Kanjanabuch T; Puttipittayathorn N; Leelahavanichkul A; Lieusuwan S; Katavetin P; Mahatanan N; Sriudom K; Chirananthavat T; Thongbor N; Eiam-Ong S
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S119-25. PubMed ID: 22043578
[TBL] [Abstract][Full Text] [Related]
18. Fas expression on peritoneal macrophages during continuous ambulatory peritoneal dialysis peritonitis.
Chen CY; Wu CY; Tsai TC; Lin WT; Lee WJ; Su CC; Chen HC; Chiang HC
Ren Fail; 2008; 30(3):297-301. PubMed ID: 18350449
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: maturity, cytokine synthesis and arachidonic acid metabolism.
McGregor SJ; Topley N; Jörres A; Speekenbrink AB; Gordon A; Gahl GM; Junor BJ; Briggs JD; Brock JH
Kidney Int; 1996 Feb; 49(2):525-33. PubMed ID: 8821840
[TBL] [Abstract][Full Text] [Related]
20. Alterations in chemotactic factor-induced responses of neutrophils and monocytes from chronic dialysis patients.
Lewis SL; Van Epps DE; Chenoweth DE
Clin Nephrol; 1988 Aug; 30(2):63-72. PubMed ID: 2846218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
